Toxicities and Associated Factors in Patients Receiving Temozolomide-Containing Regimens: A 12-Year Analysis of Hospital Data
Chen Shi,1,2 Xiong Wang,1,2 Changdong Diao,1,2 Haixia Zhu,1,2 Qi Yuan,1,2 Jinmei Liu,1,2 Shijun Li,1,2 Ming Gu,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology (HUST), Wuhan, People’s Republic of China; 2Hu...
Main Authors: | Shi C, Wang X, Diao C, Zhu H, Yuan Q, Liu J, Li S, Gu M, Zhang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/toxicities-and-associated-factors-in-patients-receiving-temozolomide-c-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Acute toxicity of temozolomide for the treatment of anaplastic astrocytoma: A case report
by: Yunni Diansari, et al.
Published: (2021-01-01) -
Transformer mineral oil ingestion induces systemic sub-acute toxicity in Wistar rats
by: Grace N. Otunga, et al.
Published: (2019-12-01) -
Acute and chronic toxicity and antimicrobial activity of the extract of Stryphnodendron adstringens (Mart.) Coville
by: Anna C. Almeida, et al. -
Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience
by: Liangzhi Zhong, et al.
Published: (2019-06-01) -
Aspergillosis in a Patient Receiving Temozolomide for the Treatment of Glioblastoma
by: Rodrigo Ramella Munhoz, et al.
Published: (2013-08-01)